Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Mutating the Highly Conserved Second Membrane-Spanning Region 9′ Leucine Residue in the α1 or β1 Subunit Produces Subunit-Specific Changes in the Function of Human α1β1 γ-Aminobutyric AcidAReceptors

Julie E. Dalziel, Graeme B. Cox, Peter W. Gage and Bryndis Birnir
Molecular Pharmacology May 2000, 57 (5) 875-882;
Julie E. Dalziel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Graeme B. Cox
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter W. Gage
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bryndis Birnir
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The properties of the human α1β1γ-aminobutyric acid (GABA)A receptors were investigated after mutation of a highly conserved leucine residue at the 9′ position in the second membrane-spanning region (TM2). The role of this residue in α1 and β1 subunits was examined by mutating the 9′ leucine to phenylalanine, tyrosine, or alanine. The mutations were in either the α1 subunit (α∗β), the β1 subunit (αβ∗), or in both subunits (α∗β∗), and the receptors were expressed in Sf9 cells. Our results show that the rate of desensitization is increased as the size and hydrophobicity of the 9′ residue in the α1 subunit is increased: Y, F > L > A, T. Mutation of L9′ in only the β1 subunit (αβ∗) to either phenylalanine or tyrosine increased the EC50 value for GABA at least 100 times, but the EC50 was unchanged in αβ∗ alanine mutants. In the 9′ α1 mutants (α∗β, α∗β∗) the GABA EC50 was minimally affected. In α∗β and α∗β∗, but not αβ∗, the peak currents evoked by millimolar concentrations of GABA were greatly reduced. The reduction in currents could only be partially accounted for by decreased expression of the receptors These findings suggest different roles for the two types of subunits in GABA activation and later desensitization of α1β1 receptors. In addition, an increase in the resting membrane conductance was recorded in alanine but not in phenylalanine and tyrosine mutants, indicating that the side chain size at the 9′ position is a major determinant of current flow in the closed conformation.

Footnotes

  • Send reprint requests to: Dr. Bryndis Birnir, Department of Cell and Molecular Physiology, Institute of Physiological Sciences, Lund University, Sölvegatan 19, S-223 62 Lund, Sweden. E-mail:bryndis.birnir{at}mphy.lu.se

  • ↵1 Present address: Department of Molecular and Cellular Physiology, Howard Hughes Medical Institute, Stanford University, Stanford, CA.

  • ↵2 Present address: Department of Cell and Molecular Physiology, Institute of Physiological Sciences, Lund University, Lund S-223 62, Sweden.

  • Abbreviations:
    GABA
    γ-aminobutyric acid
    TM2
    second membrane-spanning region
    nACh
    nicotinic acetylcholine
    MES
    2-(N-morpholino)ethanesulfonic acid
    Sf9
    Spodoptera frugiperda
    TES
    N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid
    • Received October 27, 1999.
    • Accepted February 3, 2000.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 57 (5)
Molecular Pharmacology
Vol. 57, Issue 5
1 May 2000
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Mutating the Highly Conserved Second Membrane-Spanning Region 9′ Leucine Residue in the α1 or β1 Subunit Produces Subunit-Specific Changes in the Function of Human α1β1 γ-Aminobutyric AcidAReceptors
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Mutating the Highly Conserved Second Membrane-Spanning Region 9′ Leucine Residue in the α1 or β1 Subunit Produces Subunit-Specific Changes in the Function of Human α1β1 γ-Aminobutyric AcidAReceptors

Julie E. Dalziel, Graeme B. Cox, Peter W. Gage and Bryndis Birnir
Molecular Pharmacology May 1, 2000, 57 (5) 875-882;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Mutating the Highly Conserved Second Membrane-Spanning Region 9′ Leucine Residue in the α1 or β1 Subunit Produces Subunit-Specific Changes in the Function of Human α1β1 γ-Aminobutyric AcidAReceptors

Julie E. Dalziel, Graeme B. Cox, Peter W. Gage and Bryndis Birnir
Molecular Pharmacology May 1, 2000, 57 (5) 875-882;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • The binding site for KCI807 in the androgen receptor
  • Fatty acid amide hydrolase in cisplatin nephrotoxicity
  • eCB Signaling System in hiPSC-Derived Neuronal Cultures
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics